Literature DB >> 2478359

Bronchoalveolar lavage desmosine in bleomycin-induced lung injury in marmosets and patients with adult respiratory distress syndrome.

S Idell1, R S Thrall, R Maunder, T R Martin, J McLarty, M Scott, B C Starcher.   

Abstract

Measurement of urinary desmosine in experimental models of emphysema has been used to demonstrate elastin catabolism. In order to evaluate the hypothesis that accelerated elastin degradation also occurs in association with acute lung injury characterized by fibrotic repair, we prepared acid hydrolysates of lung lavage (LL) and used a radioimmunoassay for desmosine to measure concentrations of this elastic-specific cross-link in LL. Lavage desmosine (pmol/100 microliter LL) was measured following bleomycin-induced lung injury in marmosets and was shown to be elevated at 1 week (median 6.0, range 5.1-7.8), 2 weeks (8.4, 6.2-8.7), and 4 weeks (7.6, 4.8-7.8) compared to control levels (1.8, 1.4-3.7). Elevations of lavage desmosine after bleomycin were temporarily associated with remodeling of the lung as indicated by increased total lung collagen, reduced diffusing capacity and lung compliance, and histologic evidence of pulmonary fibrosis. Bronchoalveolar lavage (BAL) desmosine was measured in patients with the Adult Respiratory Distress Syndrome (ARDS) and compared with patients at risk, patients with other interstitial lung diseases, and normal healthy controls. BAL desmosine (pmol/100 microliters) was not significantly different in patients with ARDS (3.2, 2.1-3.0), patients at risk for ARDS (2.8, 2.5-4.4), and those with interstitial lung disease (3.0, 1.7-5.3) compared to normal controls (2.9, 1.9-4.7). There were poor correlations of BAL desmosine with physiologic indices of severity of disease in patients with ARDS and those at risk. Accelerated elastolysis occurred in the lower respiratory tract during the evaluation of bleomycin-induced pulmonary fibrosis in marmosets but was undetectable in BAL of patients studied within the first 3 days of ARDS.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478359     DOI: 10.3109/01902148909062858

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  4 in total

1.  ADAM9 is a novel product of polymorphonuclear neutrophils: regulation of expression and contributions to extracellular matrix protein degradation during acute lung injury.

Authors:  Robin Roychaudhuri; Anja H Hergrueter; Francesca Polverino; Maria E Laucho-Contreras; Kushagra Gupta; Niels Borregaard; Caroline A Owen
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

2.  Induction of tissue factor by urokinase in lung epithelial cells and in the lungs.

Authors:  Sreerama Shetty; Yashodhar P Bhandary; Shwetha K Shetty; Thirunavukkarasu Velusamy; Praveenkumar Shetty; Khalil Bdeir; Margaret R Gyetko; Douglas B Cines; Steven Idell; Pierre F Neuenschwander; Clemens Ruppert; Andreas Guenther; Edward Abraham; Rashmi S Shetty
Journal:  Am J Respir Crit Care Med       Date:  2010-03-01       Impact factor: 21.405

3.  Elastin degradation products in acute lung injury induced by gastric contents aspiration.

Authors:  Pedro Ayala; Raúl Vivar; Rebeca Montalva; Pablo Olmos; Manuel Meneses; Gisella R Borzone
Journal:  Respir Res       Date:  2018-08-31

4.  Lung fluid biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis.

Authors:  Yishan Wang; Huijuan Wang; Chunfang Zhang; Chao Zhang; Huqin Yang; Ruiyue Gao; Zhaohui Tong
Journal:  Crit Care       Date:  2019-02-12       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.